Associated Papers
ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits.
Drobiova H et al.
Journal of Diabetes Research, 2025
Transcriptome analysis reveals effects of leukemogenic SHP2 mutations in biosynthesis of amino acids signaling.
Zhao Y et al.
Frontiers in Oncology, 2023
Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations.
Sheng L et al.
Open Medicine (warsaw, Poland), 2023
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.
Church AJ et al.
Nature Medicine, 2022
Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib.
Shishido SN et al.
Npj Breast Cancer, 2022
Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2.
Solman M et al.
Frontiers in Cell and Developmental Biology, 2022
Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.
Brouillard P et al.
Orphanet Journal of Rare Diseases, 2021
A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.
Bennett RL et al.
Cancer Discovery, 2019
Select a paper to view details